🇬🇧 🇫🇷
V

Valerio Therapeutics

Pharmaceutical Manufacturing · France · 200 employees

Pharmaceutical Manufacturing France B2B Est. 2014
9 Decision makers
+1 New (6 months)
200 Employees
$2M Revenue
2014 Founded

Organizational Chart of Valerio Therapeutics

Roles identified within Valerio Therapeutics's leadership team, from public professional data, updated 25 Oct 2026.

Department

Valerio Therapeutics's Full Organizational Chart

Loading…

Get their contacts on Zeliq →

Job title Department People

Decision makers at Valerio Therapeutics by function

General management

Tech & product

See all Valerio Therapeutics contacts on Zeliq

Decision makers at Valerio Therapeutics

9 identified 3 C-Level 2 VP 4 Directors +1 new (6 months)
See them on Zeliq →

Funding and news at Valerio Therapeutics

Funding

Last round Other · $4M
Total funding $54M (8 rounds)
Series A $2M May 2010
Grant $4M Jul 2013
Grant $1M Oct 2014
Post-IPO Equity $12M Sep 2016
Post-IPO Equity $15M Jul 2017
Post-IPO Equity $5M Jun 2018
Post-IPO Equity $10M Apr 2021
Post-IPO Debt $4M Apr 2022

Latest news at Valerio Therapeutics

  1. Appointment

    New Chief Executive Officer appointed — General management

Get these new hires' email and phone →

Team Structure headcount by department

Research
15
Other
9
General Management
6
Operations
3
Technical
2
Administrative
1
Customer Service
1
Education
1

How to prospect Valerio Therapeutics's departments
Research

This is where the company's largest headcount sits (15 people). Researchers respond to substance: reference publications, benchmarks or datasets relevant to their field.

Other

With 9 people, this is the organisation's second pillar. Mixed profiles gather here: a discovery-first approach works better than a packaged pitch.

General Management

6 people work in this department. General management thinks in strategic priorities: link your value proposition to one of theirs or you will not get a reply.

Operations

A team of 3 people. Process efficiency and cost control are the angles that resonate with these decision makers.

Technical

This department counts 2 people. Skip the marketing speak: these decision makers expect precise use cases, documentation and a quick proof of value.

Try the Zeliq email finder demo →

FAQ Valerio Therapeutics

Who runs Valerio Therapeutics?

The highest-ranking leadership role identified at Valerio Therapeutics is “CEO”, based on public data updated 25 Oct 2026.

How many decision makers does Valerio Therapeutics have?

9 decision makers identified, including 3 at executive level.

How do I contact a decision maker at Valerio Therapeutics?

Verified emails and phone numbers are available in Zeliq, with free credits at sign-up.

Companies similar to Valerio Therapeutics

More companies to explore

Pharmaceutical Manufacturing · France

All Pharmaceutical Manufacturing companies in France →

About Valerio Therapeutics

Valerio Therapeutics is a Pharmaceutical Manufacturing company, operating from France. The company was founded in 2014 and counts about 200 employees. Within the wider Manufacturing sector, Valerio Therapeutics focuses on the Pharmaceutical Manufacturing segment. Its customer base is mainly professional: Valerio Therapeutics operates on a B2B model. The company has secured 8 rounds of funding totalling $54M. Its estimated yearly revenue stands at about $2M. This profile compiles key information about Valerio Therapeutics, including industry, size, location, business signals, and B2B contacts, to help sales teams qualify the account and identify the right decision makers before reaching out.

Activity & Market

Valerio Therapeutics is positioned on the Pharmaceutical Manufacturing segment, within the Manufacturing sector. As a B2B company, Valerio Therapeutics primarily serves business clients and professional organisations. The company is categorised as “Public company”.